inflammation Archives - Page 2 of 2 -

More than two years after first saying it would take its lead drug into a pivotal trial, Verona

Verona says FDA backs plan to take COPD drug into phase 3

https://pharmaphorum.com/news/verona-says-fda-backs-plan-to-take-copd-drug-into-phase-3/

New drugs for breast cancer, lymphoma, multiple sclerosis and migraine are among new product launches this year that

Blockbusters in waiting: drug launches to watch in 2020

https://pharmaphorum.com/news/blockbusters-in-waiting-drug-launches-to-watch-in-2020/

A partnership between Bristol-Myers Squibb and drug development accelerator BioMotiv has yielded its first fruit just a few

BMS, BioMotiv alliance generates biopharma company Anteros

https://pharmaphorum.com/news/bms-biomotiv-alliance-generates-biopharma-company-anteros/

Celgene has picked up a third approval for its anti-inflammatory drug Otezla, although it won’t reap much commercial

Celgene gets new approval for soon-to-be-shed Otezla

https://pharmaphorum.com/news/celgene-gets-new-approval-for-soon-to-be-shed-otezla/

AstraZeneca has agreed to sell rights to three older drugs for asthma and rhinitis to Covis Pharma for

AZ sells rights to three older drugs to Covis for $350m

https://pharmaphorum.com/news/az-sells-rights-to-three-older-drugs-to-covis-for-350m/

Sales of MS and eczema drugs could top $4bn by 2022

FDA approves two biggest new drugs of 2017

https://pharmaphorum.com/news/fda-approves-two-biggest-new-drugs-2017/

But attendees warned to expect “oceanic” weather.

Janssen’s RA candidate among hot topics at EULAR

https://pharmaphorum.com/news/janssens-ra-candidate-among-hot-topics-eular/

inflammation